SPIA
GCVRZ

Steward Partners Investment Advisory’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Steward Partners Investment Advisory’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-203
Closed – – 2854
2019
Q4 		$0 Hold
203
– – ﹤0.01% 2891
2019
Q3 		$0 Hold
203
– – ﹤0.01% 2900
2019
Q2 		$0 Buy
+203
New +$101 ﹤0.01% 2763
2018
Q4 		– Sell
-203
Closed – – 2640
2018
Q3 		$0 Hold
203
– – ﹤0.01% 2832
2018
Q2 		$0 Hold
203
– – ﹤0.01% 2668
2018
Q1 		$0 Buy
203
+102
+101% +$41 ﹤0.01% 2443
2017
Q4 		$0 Hold
101
– – ﹤0.01% 2034
2017
Q3 		$0 Hold
101
– – ﹤0.01% 1856
2017
Q2 		$0 Buy
101
+100
+10,000% +$41 ﹤0.01% 1796
2017
Q1 		$0 Buy
+1
New – ﹤0.01% 1638

Steward Partners Investment Advisory's GCVRZ Position: Q1 2020 in Review

Steward Partners Investment Advisory sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 203 shares.

Steward Partners Investment Advisory first reported a position in GCVRZ in Q1 2017 and held it in 10 quarters. The position peaked at $0 in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.

  • Steward Partners Investment Advisory reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 203 Sanofi Contingent Value Rights shares in Q1 2020.
  • Steward Partners Investment Advisory first reported a position in Sanofi Contingent Value Rights in Q1 2017 and held it in 10 quarters.
  • Steward Partners Investment Advisory's Sanofi Contingent Value Rights position peaked at $0 in Q4 2019.
  • 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2020, filed 29 Apr 2020.